The lung clearance index (LCI) from the multiple-breath inert gas washout (MBW) test is an index of ventilation distribution reflecting peripheral airway function. It is more sensitive to lung involvement in CF than spirometry (ERJ 2003;22:972−9) and correlates more closely with HRCT structural lung damage (Thorax e-pub Aug 3, 2007). It was hypothesized that LCI can stabilise or even improve in a significant proportion of the cohort over the course of several years and that LCI may be higher and progress faster in patients with vs. without chronic Ps aeruginosa colonisation (PA). Methods and Subjects: CF subjects born in 1993 or later, who had performed at least 3 MBW tests over a period of >12 month (N = 35) were included and separated into 3 groups: chronic PA (CC, n = 5), intermittent PA (IC, n = 10) and never PA (NC, n = 20). Age at first LCI was 2.2 (0.2-7.5) yrs [median (range)] and follow-up time was 4.6 (1.1-11.2) yrs. Results: LCI did not correlate with age at first or final LCI, with age at diagnosis, genotype or pancreatic status. Regression analysis showed a significant improvement in LCI in relation to the MBW test number (p = 0.005) with no significant difference between first and last LCI in either group. CC had already at start a high LCI compared to NC (p < 0.01). CC also deteriorated in LCI initially when becoming chronically colonized, but 4/5 subjects improved in LCI with more intensive treatment. NC remained stable all through follow-up. Conclusion: The course of small airway function in CF as determined by LCI is variable, but in general not progressive.
Background:
The lung clearance index (LCI) from multiple-breath washout (MBW) is known to detect abnormal lung function more sensitive than spirometry in children and teenagers with Cystic fibrosis (CF). First data comparing LCI and FEV1 in adults with CF had recently been published by A. Horsley et al. The purpose of this study was to investigate LCI in adult, healthy subjects and patients with CF by a different new device. Methods: Lung function was measured in 34 healthy, non-smoking adults (18−42 years) and 13 patients with CF (19−47 years). LCI was calculated from multiple breath inert gas dilution measurements with a modified ultrasonic flow sensor (mainstream and sidestream) using 25% helium as an inert tracer gas (Exhalyzer ® D, Ecomedics, Switzerland). Spirometry including FEV1 was performed and interpreted according to the ATS/ERS recommendations (MasterScreen PFT, Erich Jaeger GmbH, Germany). Results: LCI and FEV1% predicted in healthy adults was significantly different from that in CF patients (mean: FEV1%predicted: 108% vs. 60%; LCI: 6.3 vs. 10.4; p < 0.001). In a small subgroup of four patients with normal FEV1 ( 80% predicted) LCI differed significantly from the healthy controls (mean: 8.2 vs. 6.3; p < 0.001). In CF patients LCI increased with reducing FEV1% predicted (r 2 = 0.67, p < 0.001). Conclusion: Abnormal LCI was found in the majority of adults with cystic fibrosis. LCI is even increased in adults with normal FEV1 ( 80% predicted). The modified Exhalyzer ® D is a reliable device to ascertain reproducible data for calculating LCI. Our results agree very well with those from a similar previous study (A. Horsley et al., Thorax 2007) using a modified Innocor™ system. Methods and Subjects: LCI was followed in 5 children with chronic Pseudomonas aeruginosa colonisation (CC) and 10 with intermittent colonisation (IC) diagnosed at their last MBW test. Median (range) follow-up time was 10.2 (6.7-11.2) and 6.5 (1.1-11.2) yrs, respectively, with 7 (3-10) follow-up visits in both groups. The number of i.v antibiotic courses given per year was compared. Results: LCI tended to be higher in children with CC vs IC group already at the first MBW (median 10.8 (7.8−13.6) vs 8.3 (6.0−13.0); p = 0.17). LCI improved in 4/5 with CC and 7/10 with IC during the study period, being 9.2 (7.4−10.0) and 7.4 (6.5−10.5), respectively at the last test (p = 0.07). The median (range) number of i.v antibiotic courses per subject and year during follow up was 2.1 (1.3−2.9) in CC and 1.3 (0.2−3.0) in IC (p = 0.21). Conclusion: Small airway dysfunction in CF is not necessarily progressive even in subjects with chronic or intermittent Pseudomonas aeruginosa colonisation, supporting the view that aggressive early intervention is important. All pts with CF are at risk of developing liver disease. End-stage liver disease is a significant cause of morbidity and mortality with liver transplantation (LTx) being the only effective therapy. Isolated LTx may produce considerable extrahepatic benefits for the patient. The aim of this study is to describe retrospectively the long term effect of LTx on pulmonary function, nutritional status and sputum microbiology in CF pts. Material and Methods: 5 CF pts were the recipients of 5 liver allografts (4 from cadaveric and 1 from related donor). There were 3 boys and 2 girls with a mean age at LTx of 11.4 years (range 7.5−18). Results: The mean follow-up was 4.8 years (range 1.7−6.9). Sputum cultures pre-and postLTx were analyzed. All the pts had documented positive sputum cultures before LTx (2 with S. aureus and P. aeruginosa, 1 with S. aureus and H. influenzae, 1 with H.influenzae, 1 with S.pneumoniae) and only 4 after LTx (2 with P. aeruginosa, 2 with S. aureus). All the pts were malnourished with BMI 16 before LTx which increased to 18 after LTx. Pre-and postLTx pulmonary function tests were assessed. VC and FEV1 changed from a mean of 85% and 91% of predicted preLTX to 86% and 82% of predicted postLTx respectively. Conclusions: Although complications of CF liver disease can be managed without transplantation, LTx remains the only curative treatment for liver failure. In our studies we observed improvement in nutritional status, no considerable changes in the bacterial colonization and no significant deterioration in PFTs. Therefore, liver transplantation should be considered early in the course of liver failure in pts with CF.
